nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—type 2 diabetes mellitus—metabolic syndrome X	0.979	1	CtDrD
Linagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—LEP—metabolic syndrome X	0.00109	0.0701	CbGpPWpGaD
Linagliptin—DPP4—Incretin synthesis, secretion, and inactivation—LEP—metabolic syndrome X	0.000973	0.0624	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—PLA2G7—metabolic syndrome X	0.00094	0.0602	CbGpPWpGaD
Linagliptin—CYP3A4—Liver X Receptor Pathway—NR1H3—metabolic syndrome X	0.000742	0.0475	CbGpPWpGaD
Linagliptin—CYP3A4—Liver X Receptor Pathway—SCD—metabolic syndrome X	0.000655	0.042	CbGpPWpGaD
Linagliptin—ABCB1—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.000577	0.0369	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—GHRL—metabolic syndrome X	0.000549	0.0352	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—ACE—metabolic syndrome X	0.000531	0.034	CbGpPWpGaD
Linagliptin—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—metabolic syndrome X	0.000527	0.0338	CbGpPWpGaD
Linagliptin—DPP4—blood vessel—metabolic syndrome X	0.000522	0.296	CbGeAlD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.000452	0.029	CbGpPWpGaD
Linagliptin—CYP3A4—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.000444	0.0284	CbGpPWpGaD
Linagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.000355	0.0228	CbGpPWpGaD
Linagliptin—ABCB1—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.000348	0.0223	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—GALNT2—metabolic syndrome X	0.000338	0.0216	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—AGT—metabolic syndrome X	0.000337	0.0216	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.000331	0.0212	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—LEP—metabolic syndrome X	0.00033	0.0211	CbGpPWpGaD
Linagliptin—CYP3A4—Liver X Receptor Pathway—SREBF1—metabolic syndrome X	0.000329	0.0211	CbGpPWpGaD
Linagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—metabolic syndrome X	0.000325	0.0208	CbGpPWpGaD
Linagliptin—Hypoglycaemia—Metformin—metabolic syndrome X	0.000324	0.0795	CcSEcCtD
Linagliptin—Pain in extremity—Metformin—metabolic syndrome X	0.000316	0.0775	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—TOMM40—metabolic syndrome X	0.000314	0.0201	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.000303	0.0194	CbGpPWpGaD
Linagliptin—Nasopharyngitis—Metformin—metabolic syndrome X	0.000282	0.0693	CcSEcCtD
Linagliptin—DPP4—Peptide hormone metabolism—INS—metabolic syndrome X	0.000282	0.0181	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.000279	0.0179	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—IGF1—metabolic syndrome X	0.000273	0.0175	CbGpPWpGaD
Linagliptin—Pancreatitis—Metformin—metabolic syndrome X	0.000268	0.0657	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000254	0.0623	CcSEcCtD
Linagliptin—Infestation NOS—Metformin—metabolic syndrome X	0.000243	0.0598	CcSEcCtD
Linagliptin—Infestation—Metformin—metabolic syndrome X	0.000243	0.0598	CcSEcCtD
Linagliptin—DPP4—cardiovascular system—metabolic syndrome X	0.000233	0.132	CbGeAlD
Linagliptin—DPP4—kidney—metabolic syndrome X	0.000228	0.129	CbGeAlD
Linagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.000214	0.0137	CbGpPWpGaD
Linagliptin—DPP4—adipose tissue—metabolic syndrome X	0.000205	0.117	CbGeAlD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.000204	0.0131	CbGpPWpGaD
Linagliptin—Immune system disorder—Metformin—metabolic syndrome X	0.000197	0.0485	CcSEcCtD
Linagliptin—Mediastinal disorder—Metformin—metabolic syndrome X	0.000197	0.0483	CcSEcCtD
Linagliptin—Malnutrition—Metformin—metabolic syndrome X	0.00019	0.0467	CcSEcCtD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.000187	0.012	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—PLA2G7—metabolic syndrome X	0.000177	0.0114	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.000174	0.0111	CbGpPWpGaD
Linagliptin—CYP3A4—Aflatoxin activation and detoxification—GGT1—metabolic syndrome X	0.000165	0.0106	CbGpPWpGaD
Linagliptin—Myalgia—Metformin—metabolic syndrome X	0.000162	0.0398	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000161	0.0395	CcSEcCtD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.000155	0.00996	CbGpPWpGaD
Linagliptin—Infection—Metformin—metabolic syndrome X	0.000154	0.0379	CcSEcCtD
Linagliptin—Skin disorder—Metformin—metabolic syndrome X	0.000151	0.037	CcSEcCtD
Linagliptin—DPP4—liver—metabolic syndrome X	0.000144	0.0818	CbGeAlD
Linagliptin—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000141	0.0347	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000134	0.0329	CcSEcCtD
Linagliptin—Constipation—Metformin—metabolic syndrome X	0.000133	0.0326	CcSEcCtD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—GCK—metabolic syndrome X	0.000132	0.00843	CbGpPWpGaD
Linagliptin—Urticaria—Metformin—metabolic syndrome X	0.000123	0.0303	CcSEcCtD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.000121	0.00772	CbGpPWpGaD
Linagliptin—ABCB1—blood vessel—metabolic syndrome X	0.00012	0.0684	CbGeAlD
Linagliptin—ABCB1—ABC-family proteins mediated transport—APOA1—metabolic syndrome X	0.000108	0.00692	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.000107	0.00687	CbGpPWpGaD
Linagliptin—Diarrhoea—Metformin—metabolic syndrome X	0.000106	0.0261	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—GHRL—metabolic syndrome X	0.000104	0.00664	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—ACE—metabolic syndrome X	0.0001	0.00643	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	9.97e-05	0.00638	CbGpPWpGaD
Linagliptin—Rash—Metformin—metabolic syndrome X	9.79e-05	0.024	CcSEcCtD
Linagliptin—Dermatitis—Metformin—metabolic syndrome X	9.78e-05	0.024	CcSEcCtD
Linagliptin—Headache—Metformin—metabolic syndrome X	9.72e-05	0.0239	CcSEcCtD
Linagliptin—CYP3A4—Biological oxidations—FMO3—metabolic syndrome X	8.26e-05	0.00529	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—FMO3—metabolic syndrome X	8.14e-05	0.00522	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—IGF2—metabolic syndrome X	8.02e-05	0.00514	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	7.43e-05	0.00476	CbGpPWpGaD
Linagliptin—CYP3A4—kidney—metabolic syndrome X	7.43e-05	0.0422	CbGeAlD
Linagliptin—CYP3A4—Metapathway biotransformation—EPHX2—metabolic syndrome X	7.26e-05	0.00465	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—LEP—metabolic syndrome X	6.73e-05	0.00431	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—AGT—metabolic syndrome X	6.36e-05	0.00408	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—LEP—metabolic syndrome X	6.23e-05	0.00399	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	6.14e-05	0.00393	CbGpPWpGaD
Linagliptin—ABCB1—cardiovascular system—metabolic syndrome X	5.37e-05	0.0305	CbGeAlD
Linagliptin—DPP4—Metabolism of proteins—INS—metabolic syndrome X	5.32e-05	0.00341	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—metabolic syndrome X	5.28e-05	0.00338	CbGpPWpGaD
Linagliptin—ABCB1—kidney—metabolic syndrome X	5.26e-05	0.0299	CbGeAlD
Linagliptin—DPP4—Metabolism of proteins—CCL2—metabolic syndrome X	5.24e-05	0.00336	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—IGF1—metabolic syndrome X	5.15e-05	0.0033	CbGpPWpGaD
Linagliptin—ABCB1—adipose tissue—metabolic syndrome X	4.74e-05	0.0269	CbGeAlD
Linagliptin—CYP3A4—liver—metabolic syndrome X	4.69e-05	0.0267	CbGeAlD
Linagliptin—ABCB1—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	4.1e-05	0.00263	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	3.65e-05	0.00234	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	3.5e-05	0.00224	CbGpPWpGaD
Linagliptin—ABCB1—liver—metabolic syndrome X	3.32e-05	0.0189	CbGeAlD
Linagliptin—ABCB1—Allograft Rejection—TGFB1—metabolic syndrome X	2.89e-05	0.00185	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	2.84e-05	0.00182	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	2.81e-05	0.0018	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—TNF—metabolic syndrome X	2.7e-05	0.00173	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	2.38e-05	0.00152	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—AKT1—metabolic syndrome X	2.32e-05	0.00148	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—FMO3—metabolic syndrome X	2.29e-05	0.00147	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	2.23e-05	0.00143	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	2.15e-05	0.00138	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—MLXIPL—metabolic syndrome X	2.04e-05	0.00131	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—EPHX2—metabolic syndrome X	2.04e-05	0.00131	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	1.97e-05	0.00126	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—G6PC2—metabolic syndrome X	1.92e-05	0.00123	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	1.74e-05	0.00111	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—FABP4—metabolic syndrome X	1.63e-05	0.00105	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	1.55e-05	0.000992	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	1.43e-05	0.000914	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	1.42e-05	0.000913	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—FMO3—metabolic syndrome X	1.41e-05	0.000905	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—G6PD—metabolic syndrome X	1.38e-05	0.000884	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HDAC3—metabolic syndrome X	1.35e-05	0.000863	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	1.33e-05	0.000852	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GCKR—metabolic syndrome X	1.32e-05	0.000843	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LPA—metabolic syndrome X	1.32e-05	0.000843	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	1.27e-05	0.000817	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOA5—metabolic syndrome X	1.26e-05	0.000808	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	1.26e-05	0.000806	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	1.26e-05	0.000806	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	1.2e-05	0.000771	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	1.18e-05	0.000758	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—TRIB3—metabolic syndrome X	1.17e-05	0.000752	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	1.13e-05	0.000723	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NAMPT—metabolic syndrome X	1.05e-05	0.000674	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LIPC—metabolic syndrome X	1.05e-05	0.00067	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GCK—metabolic syndrome X	1.05e-05	0.00067	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOC3—metabolic syndrome X	1.04e-05	0.000666	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CETP—metabolic syndrome X	1.01e-05	0.000646	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—FABP4—metabolic syndrome X	1.01e-05	0.000645	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	9.9e-06	0.000635	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SCARB1—metabolic syndrome X	9.66e-06	0.000619	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	9.54e-06	0.000611	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SREBF1—metabolic syndrome X	9.38e-06	0.000601	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HMGCR—metabolic syndrome X	9.12e-06	0.000584	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GOT2—metabolic syndrome X	9.12e-06	0.000584	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	8.94e-06	0.000573	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—G6PD—metabolic syndrome X	8.5e-06	0.000545	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	8.3e-06	0.000532	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	8.13e-06	0.000521	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ABCA1—metabolic syndrome X	8.13e-06	0.000521	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GCKR—metabolic syndrome X	8.11e-06	0.00052	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LPA—metabolic syndrome X	8.11e-06	0.00052	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GOT1—metabolic syndrome X	7.88e-06	0.000505	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GGT1—metabolic syndrome X	7.88e-06	0.000505	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	7.85e-06	0.000503	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOA5—metabolic syndrome X	7.77e-06	0.000498	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	7.23e-06	0.000463	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOB—metabolic syndrome X	6.68e-06	0.000428	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	6.5e-06	0.000416	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	6.48e-06	0.000415	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LIPC—metabolic syndrome X	6.44e-06	0.000413	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GCK—metabolic syndrome X	6.44e-06	0.000413	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOC3—metabolic syndrome X	6.4e-06	0.00041	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LPL—metabolic syndrome X	6.38e-06	0.000409	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CETP—metabolic syndrome X	6.22e-06	0.000398	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CD36—metabolic syndrome X	6.06e-06	0.000388	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	5.95e-06	0.000381	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	5.78e-06	0.00037	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARA—metabolic syndrome X	5.64e-06	0.000361	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	5.62e-06	0.00036	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GOT2—metabolic syndrome X	5.62e-06	0.00036	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AGT—metabolic syndrome X	5.46e-06	0.00035	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOE—metabolic syndrome X	5.35e-06	0.000343	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOA1—metabolic syndrome X	5.29e-06	0.000339	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	5.01e-06	0.000321	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	5.01e-06	0.000321	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GOT1—metabolic syndrome X	4.85e-06	0.000311	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GGT1—metabolic syndrome X	4.85e-06	0.000311	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARG—metabolic syndrome X	4.66e-06	0.000298	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—INS—metabolic syndrome X	4.57e-06	0.000293	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALB—metabolic syndrome X	4.19e-06	0.000268	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOB—metabolic syndrome X	4.12e-06	0.000264	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NOS3—metabolic syndrome X	4.01e-06	0.000257	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	4.01e-06	0.000257	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LPL—metabolic syndrome X	3.93e-06	0.000252	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CD36—metabolic syndrome X	3.74e-06	0.000239	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PTGS2—metabolic syndrome X	3.66e-06	0.000235	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARA—metabolic syndrome X	3.47e-06	0.000222	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AGT—metabolic syndrome X	3.36e-06	0.000215	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOE—metabolic syndrome X	3.3e-06	0.000211	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOA1—metabolic syndrome X	3.26e-06	0.000209	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARG—metabolic syndrome X	2.87e-06	0.000184	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—INS—metabolic syndrome X	2.82e-06	0.00018	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALB—metabolic syndrome X	2.58e-06	0.000165	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NOS3—metabolic syndrome X	2.47e-06	0.000158	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	2.26e-06	0.000145	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.84e-06	0.000118	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.13e-06	7.27e-05	CbGpPWpGaD
